- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
re: AUPH - Aurinia Pharmaceuticals
Posted on 10/20/17 at 7:41 am to cuyahoga tiger
Posted on 10/20/17 at 7:41 am to cuyahoga tiger
So what do we have so far?
1) New indication is for Dry Eye Syndrome
Aurinia has already partnered with Merck for Canine Dry Eye, but withheld the rights to human.
2) No new capital needed.
3) Market for Lupus Nephritis up to 5.5 Billion (was 2-3 billion). The buyout price just got higher....
1) New indication is for Dry Eye Syndrome
Aurinia has already partnered with Merck for Canine Dry Eye, but withheld the rights to human.
2) No new capital needed.
3) Market for Lupus Nephritis up to 5.5 Billion (was 2-3 billion). The buyout price just got higher....
This post was edited on 10/20/17 at 7:46 am
1
Posted on 10/20/17 at 7:48 am to bayoubengals88
Phase III is said to be primarily composed of healthy US and Canadian patients, which is great.
Page 1 of 1
Back to top
Follow TigerDroppings for LSU Football News